Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -10.431% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. O=C(CNC(=O)c1ccc([N+](=O)[O-])cc1)N/N=C/c1c[nH]c2ccccc12
b. CCCCN(CC)C(=O)CSc1cc(=O)n(C)c2ccccc12
Answer: b. CCCCN(CC)C(=O)CSc1cc(=O)n(C)c2ccccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)C(=O)CSc1cc(=O)n(C)c2ccccc12
CCCCN(CC)C(=O)CSc1cc(=O)n(C)c2ccccc12
N-butyl-N-ethyl-2-(1-methyl-2-oxoquinolin-4-yl)sulfanylacetamide